• AMPK–JAK2/STAT3 Signaling in Obesity-Related Asthma

  2026-09-21

  The reference study identifies reduced AMPK activity and M1 macrophage polarization as linked features of obesity-related asthma and places the JAK2/STAT3 pathway within this inflammatory circuit. By combining an obesity-related asthma mouse model with LPS-treated RAW264.7 macrophages, the work provides a mechanistic framework for studying AMPK-directed control of airway inflammation.

• Alpha-Ketoglutarate at the Tumor–Immune Interface

  2026-09-20

  Alpha-ketoglutarate is more than a TCA-cycle intermediate: it can serve as a controlled metabolic perturbation for studying PDHA1 succinylation, macrophage antigen presentation, chemotherapy resistance, and tumor–immune crosstalk. This translational perspective connects the cholangiocarcinoma mechanism reported in Nature Communications with practical assay strategy and research-use considerations.

• Praeruptorin A Blocks HCC Metastasis via ERK/MMP1

  2026-09-19

  The reference study shows that praeruptorin A suppresses migration and invasion of human hepatocellular carcinoma cells without producing the cytotoxicity or cell-cycle disruption expected from a nonspecific antiproliferative agent. Its mechanistic contribution is the identification of ERK activation and MMP1 downregulation as a linked antimetastatic pathway, supported by ERK-silencing rescue experiments.

• AT13387: Hsp90 Inhibitor Workflow Guide

  2026-09-18

  AT13387 enables mechanism-focused cancer biology research by connecting Hsp90 chaperone inhibition with client-protein loss, cell cycle arrest, and apoptosis induction. This practical guide covers concentration planning, orthogonal assays, formulation control, and how a norovirus study can inform—without overstating—membrane-rupture readouts.

• Canagliflozin Hemihydrate: Research Workflows

  2026-09-18

  Canagliflozin hemihydrate gives researchers a practical SGLT2-focused tool for glucose metabolism research, while a recent sensitized-yeast study helps define what this compound does not do: inhibit TOR under the tested conditions. This article translates that distinction into assay design, preparation guidance, comparative experiments, and troubleshooting decisions.

• 8-Chloroadenosine for RNA Workflow Control

  2026-09-17

  Use 8-Chloroadenosine as a controllable RNA synthesis inhibitor to separate transcriptional effects from RNA stability, especially in lncRNA and cytokine workflows. This practical guide combines DMSO handling, pulse-treatment design, decay assays, and orthogonal validation for molecular biology and cancer research.

• Mestranol, Lysosomal Stress, and Zebrafish Microglia

  2026-09-17

  The reference study identifies mestranol as an inducer of a reversible lysosomal storage–like state in zebrafish microglia, separating impaired intracellular digestion from defects in phagocytic uptake, cell number, or neuronal apoptosis. Its live-animal imaging, cargo-clearance assays, transcriptomics, and TFEC rescue experiments establish a useful model for studying acquired microglial lysosomal stress and environmental estrogen-associated neuroimmunotoxicity.

• DNase I (RNase-free) in Translational Neurobiology

  2026-09-16

  Translational studies increasingly combine human tissue electrophysiology with RNA, RT-PCR, chromatin, and biomarker workflows. This article explains how controlled DNA digestion can protect interpretation without being mistaken for a biological intervention. It connects the cation-dependent mechanism of DNase I (RNase-free) with practical sample preparation, competitive workflow decisions, and the human DRG findings reported for tomivosertib in neuropathic pain research.

• Dual-Action Inhibitors and p38α Dephosphorylation

  2026-09-16

  The reference preprint shows that selected kinase inhibitors can do more than occupy the p38α active site: they can reshape its activation loop and accelerate dephosphorylation by the PPM phosphatase WIP1. Biochemical assays and X-ray structures provide a mechanistic framework for designing inhibitors that combine catalytic blockade with phosphatase-assisted pathway shutdown.

• EZ Cap™ Mouse CD252(OX40L) mRNA: Assay Logic

  2026-09-15

  Explore how EZ Cap™ Mouse CD252(OX40L) mRNA (m1Ψ, HA tag) enables controlled studies of OX40L-mediated immune co-stimulation. This article connects clinical mRNA dendritic-cell evidence with rigorous mechanistic assay design while clarifying what the literature does—and does not—validate.

• Bestatin Inhibition of Leucine Aminopeptidase

  2026-09-15

  The reference study combined high-resolution X-ray crystallography of native and Bestatin-bound bovine lens leucine aminopeptidase to explain how a slow-binding inhibitor engages a dinuclear zinc active site. Its structure-based model connects Bestatin binding with a tetrahedral hydrolysis intermediate, providing a mechanistic framework for aminopeptidase activity measurement and rational inhibitor analysis.

• UTP Solution: From RNA Substrate to Assay Signal

  2026-09-14

  UTP Solution (100 mM) supports controlled RNA synthesis while helping researchers distinguish reagent performance from biological regulation. This article connects nucleotide handling to the TRIM66 olfactory receptor study and practical assay design across transcription, amplification, siRNA synthesis, and metabolism.

• Atorvastatin: HMG-CoA Reductase Inhibitor Workflows

  2026-09-14

  Atorvastatin connects mevalonate-pathway inhibition with practical assays for cholesterol metabolism, vascular phenotypes, and ferroptosis-oriented cancer research. This workflow-focused guide covers dosing, controls, cross-domain interpretation, and troubleshooting for reproducible preclinical experiments.

• Indometacin Sodium: From COX to Assay Design

  2026-09-13

  Indometacin Sodium is more than a conventional COX inhibitor: its salt chemistry, prostaglandin synthesis inhibition, and Wnt/β-catenin activity create a framework for better assay design. This guide connects clinical evidence with inflammation, pain-signaling, and remyelination research while clarifying dose translation and experimental limitations.

• Mecamylamine Hydrochloride: Assay Design

  2026-09-12

  Mecamylamine hydrochloride provides a mechanistic tool for testing nicotinic contributions to gut-brain cholinergic signaling. This article translates recent Bacteroides fragilis epilepsy findings into practical assay decisions while defining the compound’s limits in neuropsychiatric disorder research.

3718 records 4/248 page Previous Next 12345 下5页 Last page